logo
ENTITY

Erytech Pharma Sa (ERYP US)

1
Analysis
Health Care • France
Erytech Pharma S.A. operates as a biopharmaceutical company. The Company discovers and developes therapies for rare forms of cancer and orphan diseases. Erytech Pharma serves customers in France and the United States.
more
Exchange Announcement • 19 Jan 2024 23:04

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Exchange Announcement • 18 Sep 2023 16:16

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Exchange Announcement • 15 Sep 2023 16:03

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Exchange Announcement • 07 Sep 2023 17:33

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Exchange Announcement • 28 Jul 2023 00:21

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x